nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000571	0.000571	CcSEcCtD
Fosaprepitant—Immune system disorder—Prednisone—psoriasis	0.00057	0.00057	CcSEcCtD
Fosaprepitant—Malaise—Betamethasone—psoriasis	0.000569	0.000569	CcSEcCtD
Fosaprepitant—Malaise—Dexamethasone—psoriasis	0.000569	0.000569	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Triamcinolone—psoriasis	0.000567	0.000567	CcSEcCtD
Fosaprepitant—Oedema—Triamcinolone—psoriasis	0.000567	0.000567	CcSEcCtD
Fosaprepitant—Syncope—Dexamethasone—psoriasis	0.000565	0.000565	CcSEcCtD
Fosaprepitant—Syncope—Betamethasone—psoriasis	0.000565	0.000565	CcSEcCtD
Fosaprepitant—Pain—Mycophenolate mofetil—psoriasis	0.000565	0.000565	CcSEcCtD
Fosaprepitant—Constipation—Mycophenolate mofetil—psoriasis	0.000565	0.000565	CcSEcCtD
Fosaprepitant—Infection—Triamcinolone—psoriasis	0.000563	0.000563	CcSEcCtD
Fosaprepitant—Hypotension—Hydrocortisone—psoriasis	0.000563	0.000563	CcSEcCtD
Fosaprepitant—Haematuria—Methotrexate—psoriasis	0.00056	0.00056	CcSEcCtD
Fosaprepitant—Feeling abnormal—Cyclosporine—psoriasis	0.000558	0.000558	CcSEcCtD
Fosaprepitant—Shock—Triamcinolone—psoriasis	0.000558	0.000558	CcSEcCtD
Fosaprepitant—Insomnia—Prednisolone—psoriasis	0.000558	0.000558	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Cyclosporine—psoriasis	0.000554	0.000554	CcSEcCtD
Fosaprepitant—Loss of consciousness—Betamethasone—psoriasis	0.000554	0.000554	CcSEcCtD
Fosaprepitant—Loss of consciousness—Dexamethasone—psoriasis	0.000554	0.000554	CcSEcCtD
Fosaprepitant—Dizziness—Mycophenolic acid—psoriasis	0.000554	0.000554	CcSEcCtD
Fosaprepitant—Mental disorder—Prednisone—psoriasis	0.000553	0.000553	CcSEcCtD
Fosaprepitant—Malnutrition—Prednisone—psoriasis	0.000549	0.000549	CcSEcCtD
Fosaprepitant—Erythema—Prednisone—psoriasis	0.000549	0.000549	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Triamcinolone—psoriasis	0.000548	0.000548	CcSEcCtD
Fosaprepitant—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000545	0.000545	CcSEcCtD
Fosaprepitant—Insomnia—Hydrocortisone—psoriasis	0.000545	0.000545	CcSEcCtD
Fosaprepitant—Hypertension—Betamethasone—psoriasis	0.000544	0.000544	CcSEcCtD
Fosaprepitant—Hypertension—Dexamethasone—psoriasis	0.000544	0.000544	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000541	0.000541	CcSEcCtD
Fosaprepitant—Urticaria—Cyclosporine—psoriasis	0.000538	0.000538	CcSEcCtD
Fosaprepitant—Body temperature increased—Cyclosporine—psoriasis	0.000536	0.000536	CcSEcCtD
Fosaprepitant—Abdominal pain—Cyclosporine—psoriasis	0.000536	0.000536	CcSEcCtD
Fosaprepitant—Anxiety—Dexamethasone—psoriasis	0.000535	0.000535	CcSEcCtD
Fosaprepitant—Anxiety—Betamethasone—psoriasis	0.000535	0.000535	CcSEcCtD
Fosaprepitant—Vomiting—Mycophenolic acid—psoriasis	0.000533	0.000533	CcSEcCtD
Fosaprepitant—Discomfort—Dexamethasone—psoriasis	0.00053	0.00053	CcSEcCtD
Fosaprepitant—Discomfort—Betamethasone—psoriasis	0.00053	0.00053	CcSEcCtD
Fosaprepitant—Dyspepsia—Hydrocortisone—psoriasis	0.00053	0.00053	CcSEcCtD
Fosaprepitant—Rash—Mycophenolic acid—psoriasis	0.000528	0.000528	CcSEcCtD
Fosaprepitant—Dermatitis—Mycophenolic acid—psoriasis	0.000528	0.000528	CcSEcCtD
Fosaprepitant—Pain—Prednisolone—psoriasis	0.000527	0.000527	CcSEcCtD
Fosaprepitant—Urticaria—Mycophenolate mofetil—psoriasis	0.000525	0.000525	CcSEcCtD
Fosaprepitant—Headache—Mycophenolic acid—psoriasis	0.000525	0.000525	CcSEcCtD
Fosaprepitant—Decreased appetite—Hydrocortisone—psoriasis	0.000524	0.000524	CcSEcCtD
Fosaprepitant—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000523	0.000523	CcSEcCtD
Fosaprepitant—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000523	0.000523	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Methotrexate—psoriasis	0.000521	0.000521	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.00052	0.00052	CcSEcCtD
Fosaprepitant—Fatigue—Hydrocortisone—psoriasis	0.000519	0.000519	CcSEcCtD
Fosaprepitant—Urethral disorder—Methotrexate—psoriasis	0.000517	0.000517	CcSEcCtD
Fosaprepitant—Pain—Hydrocortisone—psoriasis	0.000515	0.000515	CcSEcCtD
Fosaprepitant—Oedema—Dexamethasone—psoriasis	0.000515	0.000515	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Dexamethasone—psoriasis	0.000515	0.000515	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Betamethasone—psoriasis	0.000515	0.000515	CcSEcCtD
Fosaprepitant—Oedema—Betamethasone—psoriasis	0.000515	0.000515	CcSEcCtD
Fosaprepitant—Insomnia—Triamcinolone—psoriasis	0.000513	0.000513	CcSEcCtD
Fosaprepitant—Infection—Dexamethasone—psoriasis	0.000511	0.000511	CcSEcCtD
Fosaprepitant—Infection—Betamethasone—psoriasis	0.000511	0.000511	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Prednisone—psoriasis	0.000509	0.000509	CcSEcCtD
Fosaprepitant—Feeling abnormal—Prednisolone—psoriasis	0.000508	0.000508	CcSEcCtD
Fosaprepitant—Anaemia—Prednisone—psoriasis	0.000507	0.000507	CcSEcCtD
Fosaprepitant—Shock—Dexamethasone—psoriasis	0.000506	0.000506	CcSEcCtD
Fosaprepitant—Shock—Betamethasone—psoriasis	0.000506	0.000506	CcSEcCtD
Fosaprepitant—Dyspnoea—Triamcinolone—psoriasis	0.000506	0.000506	CcSEcCtD
Fosaprepitant—Nervous system disorder—Betamethasone—psoriasis	0.000505	0.000505	CcSEcCtD
Fosaprepitant—Nervous system disorder—Dexamethasone—psoriasis	0.000505	0.000505	CcSEcCtD
Fosaprepitant—Angioedema—Prednisone—psoriasis	0.000502	0.000502	CcSEcCtD
Fosaprepitant—Hypersensitivity—Cyclosporine—psoriasis	0.000499	0.000499	CcSEcCtD
Fosaprepitant—Dyspepsia—Triamcinolone—psoriasis	0.000499	0.000499	CcSEcCtD
Fosaprepitant—Erythema multiforme—Methotrexate—psoriasis	0.000498	0.000498	CcSEcCtD
Fosaprepitant—Nausea—Mycophenolic acid—psoriasis	0.000498	0.000498	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Dexamethasone—psoriasis	0.000497	0.000497	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Betamethasone—psoriasis	0.000497	0.000497	CcSEcCtD
Fosaprepitant—Feeling abnormal—Hydrocortisone—psoriasis	0.000496	0.000496	CcSEcCtD
Fosaprepitant—Malaise—Prednisone—psoriasis	0.000495	0.000495	CcSEcCtD
Fosaprepitant—Eye disorder—Methotrexate—psoriasis	0.000493	0.000493	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000492	0.000492	CcSEcCtD
Fosaprepitant—Syncope—Prednisone—psoriasis	0.000492	0.000492	CcSEcCtD
Fosaprepitant—Tinnitus—Methotrexate—psoriasis	0.000491	0.000491	CcSEcCtD
Fosaprepitant—Urticaria—Prednisolone—psoriasis	0.00049	0.00049	CcSEcCtD
Fosaprepitant—Cardiac disorder—Methotrexate—psoriasis	0.000489	0.000489	CcSEcCtD
Fosaprepitant—Fatigue—Triamcinolone—psoriasis	0.000489	0.000489	CcSEcCtD
Fosaprepitant—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000487	0.000487	CcSEcCtD
Fosaprepitant—Asthenia—Cyclosporine—psoriasis	0.000486	0.000486	CcSEcCtD
Fosaprepitant—Pain—Triamcinolone—psoriasis	0.000485	0.000485	CcSEcCtD
Fosaprepitant—Loss of consciousness—Prednisone—psoriasis	0.000483	0.000483	CcSEcCtD
Fosaprepitant—Hypotension—Betamethasone—psoriasis	0.000481	0.000481	CcSEcCtD
Fosaprepitant—Hypotension—Dexamethasone—psoriasis	0.000481	0.000481	CcSEcCtD
Fosaprepitant—Pruritus—Cyclosporine—psoriasis	0.000479	0.000479	CcSEcCtD
Fosaprepitant—Urticaria—Hydrocortisone—psoriasis	0.000478	0.000478	CcSEcCtD
Fosaprepitant—Angiopathy—Methotrexate—psoriasis	0.000478	0.000478	CcSEcCtD
Fosaprepitant—Immune system disorder—Methotrexate—psoriasis	0.000476	0.000476	CcSEcCtD
Fosaprepitant—Body temperature increased—Hydrocortisone—psoriasis	0.000476	0.000476	CcSEcCtD
Fosaprepitant—Abdominal pain—Hydrocortisone—psoriasis	0.000476	0.000476	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Methotrexate—psoriasis	0.000475	0.000475	CcSEcCtD
Fosaprepitant—Asthenia—Mycophenolate mofetil—psoriasis	0.000474	0.000474	CcSEcCtD
Fosaprepitant—Hypertension—Prednisone—psoriasis	0.000474	0.000474	CcSEcCtD
Fosaprepitant—Pruritus—Mycophenolate mofetil—psoriasis	0.000468	0.000468	CcSEcCtD
Fosaprepitant—Feeling abnormal—Triamcinolone—psoriasis	0.000467	0.000467	CcSEcCtD
Fosaprepitant—Anxiety—Prednisone—psoriasis	0.000466	0.000466	CcSEcCtD
Fosaprepitant—Insomnia—Betamethasone—psoriasis	0.000465	0.000465	CcSEcCtD
Fosaprepitant—Insomnia—Dexamethasone—psoriasis	0.000465	0.000465	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000464	0.000464	CcSEcCtD
Fosaprepitant—Diarrhoea—Cyclosporine—psoriasis	0.000464	0.000464	CcSEcCtD
Fosaprepitant—Discomfort—Prednisone—psoriasis	0.000462	0.000462	CcSEcCtD
Fosaprepitant—Mental disorder—Methotrexate—psoriasis	0.000462	0.000462	CcSEcCtD
Fosaprepitant—Erythema—Methotrexate—psoriasis	0.000459	0.000459	CcSEcCtD
Fosaprepitant—Malnutrition—Methotrexate—psoriasis	0.000459	0.000459	CcSEcCtD
Fosaprepitant—Hypersensitivity—Prednisolone—psoriasis	0.000454	0.000454	CcSEcCtD
Fosaprepitant—Dyspepsia—Betamethasone—psoriasis	0.000453	0.000453	CcSEcCtD
Fosaprepitant—Dyspepsia—Dexamethasone—psoriasis	0.000453	0.000453	CcSEcCtD
Fosaprepitant—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000452	0.000452	CcSEcCtD
Fosaprepitant—Urticaria—Triamcinolone—psoriasis	0.000451	0.000451	CcSEcCtD
Fosaprepitant—Dysgeusia—Methotrexate—psoriasis	0.000449	0.000449	CcSEcCtD
Fosaprepitant—Body temperature increased—Triamcinolone—psoriasis	0.000448	0.000448	CcSEcCtD
Fosaprepitant—Dizziness—Cyclosporine—psoriasis	0.000448	0.000448	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Prednisone—psoriasis	0.000448	0.000448	CcSEcCtD
Fosaprepitant—Oedema—Prednisone—psoriasis	0.000448	0.000448	CcSEcCtD
Fosaprepitant—Decreased appetite—Betamethasone—psoriasis	0.000447	0.000447	CcSEcCtD
Fosaprepitant—Decreased appetite—Dexamethasone—psoriasis	0.000447	0.000447	CcSEcCtD
Fosaprepitant—Infection—Prednisone—psoriasis	0.000445	0.000445	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000444	0.000444	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Betamethasone—psoriasis	0.000444	0.000444	CcSEcCtD
Fosaprepitant—Hypersensitivity—Hydrocortisone—psoriasis	0.000444	0.000444	CcSEcCtD
Fosaprepitant—Fatigue—Dexamethasone—psoriasis	0.000444	0.000444	CcSEcCtD
Fosaprepitant—Fatigue—Betamethasone—psoriasis	0.000444	0.000444	CcSEcCtD
Fosaprepitant—Shock—Prednisone—psoriasis	0.000441	0.000441	CcSEcCtD
Fosaprepitant—Pain—Dexamethasone—psoriasis	0.00044	0.00044	CcSEcCtD
Fosaprepitant—Pain—Betamethasone—psoriasis	0.00044	0.00044	CcSEcCtD
Fosaprepitant—Nervous system disorder—Prednisone—psoriasis	0.000439	0.000439	CcSEcCtD
Fosaprepitant—Dizziness—Mycophenolate mofetil—psoriasis	0.000437	0.000437	CcSEcCtD
Fosaprepitant—Skin disorder—Prednisone—psoriasis	0.000435	0.000435	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Prednisone—psoriasis	0.000433	0.000433	CcSEcCtD
Fosaprepitant—Asthenia—Hydrocortisone—psoriasis	0.000432	0.000432	CcSEcCtD
Fosaprepitant—Vomiting—Cyclosporine—psoriasis	0.000431	0.000431	CcSEcCtD
Fosaprepitant—Rash—Cyclosporine—psoriasis	0.000427	0.000427	CcSEcCtD
Fosaprepitant—Dermatitis—Cyclosporine—psoriasis	0.000427	0.000427	CcSEcCtD
Fosaprepitant—Pruritus—Hydrocortisone—psoriasis	0.000426	0.000426	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Methotrexate—psoriasis	0.000426	0.000426	CcSEcCtD
Fosaprepitant—Headache—Cyclosporine—psoriasis	0.000425	0.000425	CcSEcCtD
Fosaprepitant—Anaemia—Methotrexate—psoriasis	0.000424	0.000424	CcSEcCtD
Fosaprepitant—Feeling abnormal—Betamethasone—psoriasis	0.000424	0.000424	CcSEcCtD
Fosaprepitant—Feeling abnormal—Dexamethasone—psoriasis	0.000424	0.000424	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Dexamethasone—psoriasis	0.000421	0.000421	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Betamethasone—psoriasis	0.000421	0.000421	CcSEcCtD
Fosaprepitant—Vomiting—Mycophenolate mofetil—psoriasis	0.00042	0.00042	CcSEcCtD
Fosaprepitant—Hypersensitivity—Triamcinolone—psoriasis	0.000418	0.000418	CcSEcCtD
Fosaprepitant—Rash—Mycophenolate mofetil—psoriasis	0.000417	0.000417	CcSEcCtD
Fosaprepitant—Dermatitis—Mycophenolate mofetil—psoriasis	0.000416	0.000416	CcSEcCtD
Fosaprepitant—Headache—Mycophenolate mofetil—psoriasis	0.000414	0.000414	CcSEcCtD
Fosaprepitant—Malaise—Methotrexate—psoriasis	0.000414	0.000414	CcSEcCtD
Fosaprepitant—Diarrhoea—Hydrocortisone—psoriasis	0.000412	0.000412	CcSEcCtD
Fosaprepitant—Urticaria—Betamethasone—psoriasis	0.000409	0.000409	CcSEcCtD
Fosaprepitant—Urticaria—Dexamethasone—psoriasis	0.000409	0.000409	CcSEcCtD
Fosaprepitant—Dizziness—Prednisolone—psoriasis	0.000408	0.000408	CcSEcCtD
Fosaprepitant—Asthenia—Triamcinolone—psoriasis	0.000407	0.000407	CcSEcCtD
Fosaprepitant—Abdominal pain—Dexamethasone—psoriasis	0.000407	0.000407	CcSEcCtD
Fosaprepitant—Body temperature increased—Dexamethasone—psoriasis	0.000407	0.000407	CcSEcCtD
Fosaprepitant—Abdominal pain—Betamethasone—psoriasis	0.000407	0.000407	CcSEcCtD
Fosaprepitant—Body temperature increased—Betamethasone—psoriasis	0.000407	0.000407	CcSEcCtD
Fosaprepitant—Insomnia—Prednisone—psoriasis	0.000405	0.000405	CcSEcCtD
Fosaprepitant—Nausea—Cyclosporine—psoriasis	0.000403	0.000403	CcSEcCtD
Fosaprepitant—Pruritus—Triamcinolone—psoriasis	0.000401	0.000401	CcSEcCtD
Fosaprepitant—Cough—Methotrexate—psoriasis	0.0004	0.0004	CcSEcCtD
Fosaprepitant—Dizziness—Hydrocortisone—psoriasis	0.000398	0.000398	CcSEcCtD
Fosaprepitant—Dyspepsia—Prednisone—psoriasis	0.000394	0.000394	CcSEcCtD
Fosaprepitant—Nausea—Mycophenolate mofetil—psoriasis	0.000393	0.000393	CcSEcCtD
Fosaprepitant—Chest pain—Methotrexate—psoriasis	0.000391	0.000391	CcSEcCtD
Fosaprepitant—Decreased appetite—Prednisone—psoriasis	0.00039	0.00039	CcSEcCtD
Fosaprepitant—Rash—Prednisolone—psoriasis	0.000389	0.000389	CcSEcCtD
Fosaprepitant—Dermatitis—Prednisolone—psoriasis	0.000388	0.000388	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000388	0.000388	CcSEcCtD
Fosaprepitant—Fatigue—Prednisone—psoriasis	0.000386	0.000386	CcSEcCtD
Fosaprepitant—Headache—Prednisolone—psoriasis	0.000386	0.000386	CcSEcCtD
Fosaprepitant—Discomfort—Methotrexate—psoriasis	0.000386	0.000386	CcSEcCtD
Fosaprepitant—Constipation—Prednisone—psoriasis	0.000383	0.000383	CcSEcCtD
Fosaprepitant—Vomiting—Hydrocortisone—psoriasis	0.000383	0.000383	CcSEcCtD
Fosaprepitant—Rash—Hydrocortisone—psoriasis	0.00038	0.00038	CcSEcCtD
Fosaprepitant—Dermatitis—Hydrocortisone—psoriasis	0.000379	0.000379	CcSEcCtD
Fosaprepitant—Headache—Hydrocortisone—psoriasis	0.000377	0.000377	CcSEcCtD
Fosaprepitant—Dizziness—Triamcinolone—psoriasis	0.000375	0.000375	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Methotrexate—psoriasis	0.000374	0.000374	CcSEcCtD
Fosaprepitant—Infection—Methotrexate—psoriasis	0.000372	0.000372	CcSEcCtD
Fosaprepitant—Feeling abnormal—Prednisone—psoriasis	0.000369	0.000369	CcSEcCtD
Fosaprepitant—Asthenia—Dexamethasone—psoriasis	0.000369	0.000369	CcSEcCtD
Fosaprepitant—Asthenia—Betamethasone—psoriasis	0.000369	0.000369	CcSEcCtD
Fosaprepitant—Nervous system disorder—Methotrexate—psoriasis	0.000367	0.000367	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Prednisone—psoriasis	0.000366	0.000366	CcSEcCtD
Fosaprepitant—Nausea—Prednisolone—psoriasis	0.000366	0.000366	CcSEcCtD
Fosaprepitant—Pruritus—Dexamethasone—psoriasis	0.000364	0.000364	CcSEcCtD
Fosaprepitant—Pruritus—Betamethasone—psoriasis	0.000364	0.000364	CcSEcCtD
Fosaprepitant—Skin disorder—Methotrexate—psoriasis	0.000364	0.000364	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Methotrexate—psoriasis	0.000362	0.000362	CcSEcCtD
Fosaprepitant—Vomiting—Triamcinolone—psoriasis	0.000361	0.000361	CcSEcCtD
Fosaprepitant—Nausea—Hydrocortisone—psoriasis	0.000358	0.000358	CcSEcCtD
Fosaprepitant—Rash—Triamcinolone—psoriasis	0.000358	0.000358	CcSEcCtD
Fosaprepitant—Dermatitis—Triamcinolone—psoriasis	0.000357	0.000357	CcSEcCtD
Fosaprepitant—Urticaria—Prednisone—psoriasis	0.000356	0.000356	CcSEcCtD
Fosaprepitant—Headache—Triamcinolone—psoriasis	0.000355	0.000355	CcSEcCtD
Fosaprepitant—Abdominal pain—Prednisone—psoriasis	0.000354	0.000354	CcSEcCtD
Fosaprepitant—Body temperature increased—Prednisone—psoriasis	0.000354	0.000354	CcSEcCtD
Fosaprepitant—Diarrhoea—Dexamethasone—psoriasis	0.000352	0.000352	CcSEcCtD
Fosaprepitant—Diarrhoea—Betamethasone—psoriasis	0.000352	0.000352	CcSEcCtD
Fosaprepitant—Hypotension—Methotrexate—psoriasis	0.00035	0.00035	CcSEcCtD
Fosaprepitant—Dizziness—Dexamethasone—psoriasis	0.00034	0.00034	CcSEcCtD
Fosaprepitant—Dizziness—Betamethasone—psoriasis	0.00034	0.00034	CcSEcCtD
Fosaprepitant—Insomnia—Methotrexate—psoriasis	0.000339	0.000339	CcSEcCtD
Fosaprepitant—Nausea—Triamcinolone—psoriasis	0.000337	0.000337	CcSEcCtD
Fosaprepitant—Dyspnoea—Methotrexate—psoriasis	0.000334	0.000334	CcSEcCtD
Fosaprepitant—Somnolence—Methotrexate—psoriasis	0.000333	0.000333	CcSEcCtD
Fosaprepitant—Hypersensitivity—Prednisone—psoriasis	0.00033	0.00033	CcSEcCtD
Fosaprepitant—Dyspepsia—Methotrexate—psoriasis	0.00033	0.00033	CcSEcCtD
Fosaprepitant—Vomiting—Betamethasone—psoriasis	0.000327	0.000327	CcSEcCtD
Fosaprepitant—Vomiting—Dexamethasone—psoriasis	0.000327	0.000327	CcSEcCtD
Fosaprepitant—Decreased appetite—Methotrexate—psoriasis	0.000326	0.000326	CcSEcCtD
Fosaprepitant—Rash—Betamethasone—psoriasis	0.000324	0.000324	CcSEcCtD
Fosaprepitant—Rash—Dexamethasone—psoriasis	0.000324	0.000324	CcSEcCtD
Fosaprepitant—Dermatitis—Dexamethasone—psoriasis	0.000324	0.000324	CcSEcCtD
Fosaprepitant—Dermatitis—Betamethasone—psoriasis	0.000324	0.000324	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Methotrexate—psoriasis	0.000323	0.000323	CcSEcCtD
Fosaprepitant—Fatigue—Methotrexate—psoriasis	0.000323	0.000323	CcSEcCtD
Fosaprepitant—Headache—Betamethasone—psoriasis	0.000322	0.000322	CcSEcCtD
Fosaprepitant—Headache—Dexamethasone—psoriasis	0.000322	0.000322	CcSEcCtD
Fosaprepitant—Asthenia—Prednisone—psoriasis	0.000322	0.000322	CcSEcCtD
Fosaprepitant—Pain—Methotrexate—psoriasis	0.00032	0.00032	CcSEcCtD
Fosaprepitant—Pruritus—Prednisone—psoriasis	0.000317	0.000317	CcSEcCtD
Fosaprepitant—Feeling abnormal—Methotrexate—psoriasis	0.000309	0.000309	CcSEcCtD
Fosaprepitant—Diarrhoea—Prednisone—psoriasis	0.000307	0.000307	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Methotrexate—psoriasis	0.000306	0.000306	CcSEcCtD
Fosaprepitant—Nausea—Betamethasone—psoriasis	0.000306	0.000306	CcSEcCtD
Fosaprepitant—Nausea—Dexamethasone—psoriasis	0.000306	0.000306	CcSEcCtD
Fosaprepitant—Urticaria—Methotrexate—psoriasis	0.000298	0.000298	CcSEcCtD
Fosaprepitant—Dizziness—Prednisone—psoriasis	0.000296	0.000296	CcSEcCtD
Fosaprepitant—Body temperature increased—Methotrexate—psoriasis	0.000296	0.000296	CcSEcCtD
Fosaprepitant—Abdominal pain—Methotrexate—psoriasis	0.000296	0.000296	CcSEcCtD
Fosaprepitant—Vomiting—Prednisone—psoriasis	0.000285	0.000285	CcSEcCtD
Fosaprepitant—Rash—Prednisone—psoriasis	0.000283	0.000283	CcSEcCtD
Fosaprepitant—Dermatitis—Prednisone—psoriasis	0.000282	0.000282	CcSEcCtD
Fosaprepitant—Headache—Prednisone—psoriasis	0.000281	0.000281	CcSEcCtD
Fosaprepitant—Hypersensitivity—Methotrexate—psoriasis	0.000276	0.000276	CcSEcCtD
Fosaprepitant—Asthenia—Methotrexate—psoriasis	0.000269	0.000269	CcSEcCtD
Fosaprepitant—Nausea—Prednisone—psoriasis	0.000266	0.000266	CcSEcCtD
Fosaprepitant—Pruritus—Methotrexate—psoriasis	0.000265	0.000265	CcSEcCtD
Fosaprepitant—Diarrhoea—Methotrexate—psoriasis	0.000256	0.000256	CcSEcCtD
Fosaprepitant—Dizziness—Methotrexate—psoriasis	0.000248	0.000248	CcSEcCtD
Fosaprepitant—Vomiting—Methotrexate—psoriasis	0.000238	0.000238	CcSEcCtD
Fosaprepitant—Rash—Methotrexate—psoriasis	0.000236	0.000236	CcSEcCtD
Fosaprepitant—Dermatitis—Methotrexate—psoriasis	0.000236	0.000236	CcSEcCtD
Fosaprepitant—Headache—Methotrexate—psoriasis	0.000235	0.000235	CcSEcCtD
Fosaprepitant—Nausea—Methotrexate—psoriasis	0.000222	0.000222	CcSEcCtD
